Table 1.
Patient details | N (%) |
---|---|
Age at Surgery | |
Median | 60 |
IQR | 53–68 |
Range | 29 – 84 |
Histology | |
SCC | 75 (94%) |
Adenoid Cystic | 4 (5%) |
Ameloblastoma | 1 (1%) |
AJCC Stage (1) | |
I | 11 (14%) |
II | 10 (13%) |
III | 13 (17%) |
IVa | 41 (54%) |
IVb | 1 (1%) |
Additional Treatment | |
None | 17 (21%) |
Radiation | 30 (38%) |
Chemoradiation | 33 (41%) |
Treatment for recurrence | 14 (18%) |
Treatment for second primary | 15 (19%) |
Free Flap | |
ALT | 18 (22%) |
Fibula | 36 (45%) |
Radial Forearm | 18 (22%) |
Other | 8 (10%) |
Second Simultaneous Flap | 3 (4%) |
Composite Resection | 56 (70%) |
Oral Tongue Resection | 24 (30%) |
Composite Site | |
Lateral | 38 (68%) |
Anterior | 18 (32%) |
Oropharyngeal Component | 28 (35%) |
Extent of Tongue Resection | |
None | 29 (36%) |
< 1/3 | 14 (18%) |
1/3 – 1/2 | 29 (36%) |
> 1/2 | 8 (10%) |
Mandibulectomy | |
Segmental | 45 of 56 (80%) |
Marginal | 11 of 56 (20%) |
Four patients were missing AJCC Stage.